Docetaxel

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC

Drug Information

Target Indication

PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC

Clinical Trial

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

GMAB

Genmab A/S

Related Pipeline

Platinum-resistant Ovarian Cancer

Diffuse Large B-Cell Lymphoma

Follicular Lymphoma (FL)

Non Small Cell Lung Cancer Metastatic

Head and Neck Cancer